Header cover image

Swiss Pharmaceuticals & Biotech Blue chip stocks

Results

3

0 new

3 companies

Lonza Group

Market Cap: CHF 34.2b

Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

LONN

CHF 490.30

7D

1.0%

1Y

-13.8%

Galderma Group

Market Cap: CHF 40.4b

Operates as a dermatology company worldwide.

GALD

CHF 172.15

7D

6.6%

1Y

54.7%

Sandoz Group

Market Cap: CHF 29.0b

Develops, manufactures, and markets generic and biosimilars worldwide.

SDZ

CHF 67.04

7D

4.1%

1Y

56.8%